NEW YORK, Sept. 3, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds buyers of TG Therapeutics, Inc. securities TGTX between January 15, 2020 and May 31, 2022, both dates inclusive (the “Class Period”), the important September 16, 2022 Deadline for Lead Plaintiff.

SO WHAT: If you purchased TG Therapeutics securities during the Class Period, you may be entitled to compensation without payment of expenses or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To participate in TG Therapeutics’ class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=7662 or call Phillip Kim, Esq. toll free at 866-767-3653 or by email [email protected] or [email protected] for information about the Class Action. A class action lawsuit has already been filed. If you want to appear as lead plaintiff, you must call the court by September 16, 2022 at the latest. A lead plaintiff is a representative party acting on behalf of other group members in conducting the litigation.

WHY ROSES LAW: We encourage investors to select qualified advisors with a track record in leadership positions. Frequently, companies that issue notices do not have comparable experience, resources, or meaningful recognition from peers. Many of these law firms do not actually conduct securities class actions, but are merely intermediaries who refer clients or work with law firms who actually hear the cases. Be wise in choosing a lawyer. The Rosen law firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivatives litigation. Rosen Law Firm has achieved the largest-ever settlement of a securities class action lawsuit against a Chinese company. Rosen Law Firm was ranked #1 in 2017 by ISS Securities Class Action Services for the number of securities class action settlements. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. 2019 alone…